Astrana Health Inc reports results for the quarter ended in September 30 - Earnings Summary
08/11/2024 04:15
* Astrana Health Inc ASTH.OQ reported quarterly adjusted
earnings of 33 cents per share for the quarter ended September
30, lower than the same quarter last year, when the company
reported EPS of 47 cents. The mean expectation of ten analysts
for the quarter was for earnings of 32 cents per share. Wall
Street expected results to range from 26 cents to 40 cents per
share.
* Revenue rose 37.5% to $478.71 million from a year ago;
analysts
expected $462.38 million.
* Astrana Health Inc's reported EPS for the quarter was 33
cents.
* The company reported quarterly net income of $16.09
million.
* Astrana Health Inc shares had risen by 2.7% this
quarter and
gained 55.3% so far this year.
FORECAST CHANGES
* The mean earnings estimate of analysts had fallen by
about 13.7%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
RECOMMENDATIONS
* The current average analyst rating on the shares is
"strong buy"
and the breakdown of recommendations is 9 "strong buy" or
"buy," 1 "hold" and no "sell" or "strong sell."
* The average consensus recommendation for the healthcare
facilities & services peer group is "buy."
Wall Street's median 12-month price target for Astrana Health
Inc is $62.00
This summary was machine generated from LSEG data November 8 at
04:14 a.m. UTC. All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2024 0.32 0.33 Beat
Jun. 30 2024 0.39 0.40 Beat
Mar. 31 2024 0.30 0.31 Beat
Dec. 31 2023 0.15 0.26 Beat